Follow us on X
Follow us on LinkedIn
Follow us on Youtube
Discover RISE d.o.o


Real-world evidence for decisions in diabetes


Randomised controlled trials (RCTs) are the cornerstone of evidence-based medicine. However, the digitisation of real-world data (RWD), including data from devices, wearables, and electronic health records in large national registries, provides opportunities to demonstrate the efficacy and safety of innovative technologies, including drugs, devices, diagnostics, and digital health. These data are particularly relevant to long-term conditions such as diabetes mellitus, where drugs, lifestyle interventions, and digital technologies often work together. To better utilise RWD in diabetes for regulatory decision-making, the development of standards, guidance and an assessment of the efficacy-to-effectiveness gap is needed. REDDIE (Real-World Evidence for Decisions in Diabetes) aims to explore how RWD can complement RCTs to improve the efficacy, safety, and value for money of technologies to prevent and treat diabetes. The overall aim of REDDIE is to support the use of RWD in diabetes and health-related research, which will maximise Europe’s scientific expertise and know-how to benefit people with diabetes, resulting in safer, more efficient, and cost-effective interventions.

Julia Mader
Medizinische Universität Graz
Horizon Europe & sub-programmes
48 months (January 2023 - December 2026)
Project funding
€ 4,788,833.75
Project partners
Project website
Your contact
Martina Radanović
Project Manager
About Eurice

Eurice offers knowledge-based consultancy services in project and innovation management.

Eurice Head Office
Heinrich-Hertz-Allee 1
66386 St. Ingbert
Phone: +49 6894 388130
Eurice Berlin
Alt-Reinickendorf 25
13407 Berlin
Phone: +49 30 374415840